ABOUT LUX

Lux Biosciences is a clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases. With a Phase 3 clinical trial in noninfectious uveitis ongoing, and several exciting earlier-stage projects, Lux is building a revenue-generating, high-growth, and sustainable ophthalmic company.